News Quantified

CLPBY – coloplast as sp/adr (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Coloplast A/S (OTCMKTS: CLPBY) was upgraded by analysts at UBS Group AG from a "strong sell" rating to a "hold" rating.

Biolevate's raises €6M to helps medical writers keep up with the pace of new drugs [Yahoo! Finance]

Biolevate's raises €6M to helps medical writers keep up with the pace of new drugs [TechCrunch]

Coloplast A/S (OTCMKTS: CLPBY) was upgraded by analysts at Hsbc Global Res from a "moderate sell" rating to a "hold" rating.

North America Ostomy Drainage Bags (Colostomy, Ileostomy, and Urostomy) Market Outlook 2023-2024 & 2028 with Competitive Analysis of Coloplast, ConvaTec, B. Braun, Hollister, and Salts Healthcare [Yahoo! Finance]

Top News Gainers

3/16 COLOPLAST A/S/ADR (OTCMKTS: CLPBY) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 6.0%

2/6 Coloplast A/S 2020 Q1 - Results - Earnings Call Presentation [Seeking Alpha] 2.3%

11/26 COLOPLAST A/S/ADR (OTCMKTS: CLPBY) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. 2.0%

1/13 Brett Girard's Top Picks: Jan. 13, 2020 [Business News Network (BNN) Energy & Resources (Canada)] 1.3%

4/29 COLOPLAST A/S/ADR (OTCMKTS: CLPBY) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 0.7%

2/26 COLOPLAST A/S/ADR (OTCMKTS: CLPBY) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 0.7%

4/17 COLOPLAST A/S/ADR (OTCMKTS: CLPBY) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 0.6%

3/18 COLOPLAST A/S/ADR (OTCMKTS: CLPBY) was upgraded by analysts at JPMorgan Chase & Co. from an "underweight" rating to a "neutral" rating. 0.5%

8/14 Coloplast A/S (CLPBF) CEO Kristian Villumsen on Q3 2019 Results - Earnings Call Transcript [Seeking Alpha] 0.4%

3/4 COLOPLAST A/S/ADR (OTCMKTS: CLPBY) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 0.3%

Top News Decliners

3/10 COLOPLAST A/S/ADR (OTCMKTS: CLPBY) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -3.1%

11/10 Coloplast A/S (CLPBF) CEO Kristian Villumsen on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] -1.6%

10/8 COLOPLAST A/S/ADR (OTCMKTS: CLPBY) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. -1.6%

2/20 COLOPLAST A/S/ADR (OTCMKTS: CLPBY) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -1.3%

2/7 Coloplast A/S (CLPBF) CEO Kristian Villumsen on Q1 2020 Results - Earnings Call Transcript [Seeking Alpha] -1.0%

4/16 COLOPLAST A/S/ADR (OTCMKTS: CLPBY) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $17.00 price target on the stock. -1.0%

12/3 Coloplast A/S (CPH:COLO B) Will Pay A ø12.00 Dividend In 3 Days [Yahoo! Finance News] -0.8%

4/20 COLOPLAST A/S/ADR (OTCMKTS: CLPBY) had its "neutral" rating re-affirmed by analysts at JPMorgan Chase & Co.. -0.4%

6/4 Coloplast says reviewing its urology business: Reuters [Reuters] -0.4%

7/19 COLOPLAST A/S/ADR (OTCMKTS: CLPBY) was downgraded by analysts at Barclays PLC from an "overweight" rating to an "equal weight" rating. -0.3%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day